Newly-formed Semdor Pharma Group becomes one of Europe’s leading pharmaceutical companies for narcotics and medical cannabisPosted by On

Cannabis prescription slip


++ PS Group and Cannamedical Pharma combine to form Semdor Group ++
++ With 160 employees in Germany and >65M € in annual revenue, Semdor comprises a leading narcotics services and product platform in the European pain therapy sector
++ Semdor aims to bring patients, doctors and pharmacies the broadest array of both synthetic and natural medicinal options for pain therapy and other conditions ++
++ Semdor is backed by >40M € in new capital, which will be used for growth initiatives including doubling the narcotics processing, storage and services capacity at PS Group’s headquarters location in Meerbusch, Germany ++

Cologne, January 2021 – The formation of Semdor Pharma Group establishes one of Europe’s leading pharmaceutical groups specialized in narcotics and medical cannabis. Semdor Pharma Group has been formed through the combination of the German narcotics services market leader PS Group (including subsidiaries PS Pharma Services, PB Pharma and PS Marketing & Outsourcing) and Cannamedical Pharma, which is the leading independent medical cannabis wholesaler in Germany. With this combination, Semdor offers European wholesalers, suppliers and pharmacies the broadest array of narcotic medicines (both synthetic and natural) and provides key narcotic and medical cannabis players the broadest…

Original Author Link click here to read complete story..


++ PS Group and Cannamedical Pharma combine to form Semdor Group ++
++ With 160 employees in Germany and >65M € in annual revenue, Semdor comprises a leading narcotics services and product platform in the European pain therapy sector
++ Semdor aims to bring patients, doctors and pharmacies the broadest array of both synthetic and natural medicinal options for pain therapy and other conditions ++
++ Semdor is backed by >40M € in new capital, which will be used for growth initiatives including doubling the narcotics processing, storage and services capacity at PS Group’s headquarters location in Meerbusch, Germany ++

Cologne, January 2021 – The formation of Semdor Pharma Group establishes one of Europe’s leading pharmaceutical groups specialized in narcotics and medical cannabis. Semdor Pharma Group has been formed through the combination of the German narcotics services market leader PS Group (including subsidiaries PS Pharma Services, PB Pharma and PS Marketing & Outsourcing) and Cannamedical Pharma, which is the leading independent medical cannabis wholesaler in Germany. With this combination, Semdor offers European wholesalers, suppliers and pharmacies the broadest array of narcotic medicines (both synthetic and natural) and provides key narcotic and medical cannabis players the broadest…



Source link

News

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.